HealthEquity

HealthEquity, Inc. provides range of solutions for managing health care accounts. The firm’s offers its solutions for employers, health plans, brokers, consultants and financial advisors. Its services include HAS, FSA, HRA, DCRA, 401(k), Commuter, COBRA and HIA. It also offers products like healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements, and healthcare incentives. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

HQY reports strong Q1 performance, faces challenges in seasonality and yield expectations

HQY's Q1 performance reflects strong growth and positive financial results, driven by increased HSA adoption and employer interest. However, the company faces challenges related to seasonality and yield expectations. To capitalize on opportunities, HQY should focus on reaching its enhanced rates target and addressing service fee pressures.

HealthEquity reports robust Q2 performance and eyes market expansion

HealthEquity's strong Q2 performance, driven by revenue and EBITDA growth, is supported by the enhanced rates product and expanded network partner footprint. While facing short-term challenges in interchange revenue and M&A environment changes, the company is well-positioned to capitalize on opportunities presented by market dynamics and regulatory discussions.

HealthEquity reports robust Q3 performance and optimistic fiscal '25 outlook

HealthEquity's Q3 performance showcased strong financial results, with raised fiscal '24 guidance and optimistic initial fiscal '25 guidance. The company is well-positioned to navigate challenges and capitalize on opportunities, particularly in expanding its market presence and enhancing customer satisfaction.

HealthEquity (HQY) posts record earnings, eyes growth through innovation

HealthEquity (HQY) delivered strong financial results, exceeding expectations and demonstrating growth across key metrics.
While facing challenges in certain business segments, the company's focus on technology, customer experience, and long-term quality positions it well for the future.
Opportunities for R&D acceleration, innovation through M&A, and expansion of product offerings present avenues for sustained growth and competitive advantage.

HealthEquity reports robust Q1 results, raises fiscal '24 guidance

HealthEquity's Q1 performance reflects strong financial growth and stability, with revenue, EBITDA, and HSA metrics showing positive trends.
The company's proactive approach to guidance revision, service fee optimization, and strategic partnerships positions it well for future success.
Challenges in managing fee pressures, COBRA impact, and M&A environment slowdown require focused strategies for sustained growth and market leadership.

HealthEquity reports robust Q2 results, eyes growth amid market shifts

HealthEquity's Q2 results reflect strong financial performance and strategic positioning for future growth.
Despite challenges in revenue consistency and market dynamics, the company's strengths in service quality and market leadership are key assets.
Opportunities in revenue growth, legislative changes, and market demand provide avenues for HealthEquity's continued success.

HealthEquity reports strong Q3 growth and bullish outlook for fiscal '25

HealthEquity's Q3 2024 earnings call highlighted impressive financial performance, strategic acquisitions, and optimistic guidance for fiscal '25, underlining the company's growth trajectory and market positioning.
While facing challenges in integrating acquisitions, maintaining competitive pricing, and managing asset maturation, HealthEquity remains focused on growth opportunities through enhanced yield products and consumer empowerment.
The company's emphasis on stability, profitability, and reinvestments, coupled with a proactive approach to engaging investors, sets the stage for continued success and market differentiation in the evolving healthcare landscape.

HealthEquity reports robust Q4 earnings, eyes growth through innovation

HealthEquity delivered strong financial results in Q4 2024, showcasing robust revenue growth and operational performance.
The company's focus on enhancing shareholder value, strategic mergers, and technology investments positions it well for future growth.
Challenges in pricing pressures and technology spend trends require careful navigation, while opportunities in HSA cash rates and digital innovations offer avenues for expansion.
Overall, HealthEquity's performance highlights resilience, strategic foresight, and a commitment to driving long-term value for stakeholders.

HealthEquity reports robust Q1 results, eyes cost savings and growth

HealthEquity's Q1 performance reflects strong growth in revenue, EBITDA, and HSA assets, underlining its market strength and operational efficiency.
The company's focus on cost savings, customer experience enhancement, and new sales growth positions it well for future success and market expansion.
While facing challenges in transitioning processes and managing costs, HealthEquity is leveraging opportunities in technology and market expansion to drive continued growth.

HealthEquity reports robust Q2 growth, unveils innovative healthcare payment options

HealthEquity's Q2 performance reflects strong growth and strategic initiatives to enhance healthcare payment options.
While facing challenges in margins and market conditions, the company's focus on innovation and team efforts bode well for future success.
Opportunities lie in leveraging HPAs, digital integration, and market expansion to drive continued growth and customer value.
Overall, HealthEquity's performance and outlook demonstrate resilience and a commitment to driving healthcare financial solutions.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

HealthEquity, Inc. engages in the provision of technology-enabled services for healthcare and spending decisions. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.

HealthEquity (HQY) witnessed strong growth in Service, Custodial and Interchange segments in Q2.

HealthEquity (HQY) Q2 Earnings and Revenues Beat Estimates

HealthEquity, Inc. (HQY) CEO Jon Kessler on Q2 2021 Results - Earnings Call Transcript

Shares of HealthEquity (NASDAQ:HQY) moved lower by 5.16% after the company reported Q2 results.

Recap: HealthEquity Q2 Earnings

Highlights of the second quarter include:

HealthEquity Reports Second Quarter Results, Raises WageWorks Synergy Target

Alarm.com

Bottomline Technologies

Mercer International

Stoneridge

Investors who can figure out the overpriced toxic stocks and shun them at the right time are the ones that are likely to benefit.

These 5 Toxic Stocks Could be Poisoning Your Portfolio

Even after a 38% rise since the March 23 lows of this year, at the current price of around $58 per share we believe HealthEquity, the largest health savings account non-bank custodian, looks attractive and it has more room for growth. HealthEquity stock has rallied from $42 to $58 off the.

Should You Buy HealthEquity Stock At $58?

DRAPER, Utah, July  13, 2020  (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), today announced the closing of the underwritten public offering of 4,600,000 shares of its common stock. The gross proceeds to HealthEquity from the offering are $257,600,000. Additionally, HealthEquity has granted the underwriters a 30-day option to purchase up to an additional 690,000 shares. HealthEquity intends to use the net proceeds from the offering to free up additional capital for organic and inorganic growth by pre-paying $200 million under its term loan facility, with the remaining proceeds to be used for general corporate purposes, which may include additional pre-payments under its term loan facility and/or potential acquisitions.

HealthEquity Announces Closing of Follow-on Offering

HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock?

HealthEquity (HQY) Up 2.3% Since Last Earnings Report: Can It Continue?

Health Savings Score allows employers to quickly gauge employee saving behavior and develop tailored strategies to improve Health Savings Score allows employers to quickly gauge employee saving behavior and develop tailored strategies to improve

Employers can now measure employee health savings with new HealthEquity tool

Short-term challenges have kept HealthEquity’s stock down this year, but the business seems poised for strong growth.

The Recovery Stock the Market Missed

DRAPER, Utah, June  26, 2020  (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), today announced that Tyson Murdock has been appointed Executive Vice President and Deputy Chief Financial Officer, effective July 1, 2020, and will succeed Darcy Mott as Chief Financial Officer (CFO) April 1, 2021. Mr. Mott will continue in his current position as Executive Vice President and CFO through March 31, 2021 to ensure a smooth transition and completion of the fiscal year 2021 Form 10-K filing for the Company and will then transition into an advisory role to the Chief Executive Officer (CEO).

HealthEquity Announces CFO Transition

DRAPER, Utah, June  15, 2020  (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), today announced additional information regarding its 2020 Annual Meeting of Stockholders (the “Annual Meeting”). As previously announced, the Annual Meeting will be held on Thursday, June 25, 2020, at 10:00 a.m. MDT.

HealthEquity 2020 Annual Meeting of Stockholders to be held Virtually

HealthEquity Earnings: Pandemic Pains, Opportunity For Long-Term Gains

HealthEquity: Discussing The Provisions Of The CARES Act

Shares plunged after the company reported quarterly results that missed the mark. Here are the must-know details.

Why HealthEquity Stock Is Sinking Today

HealthEquity (HQY) witnessed strong growth in Service, Custodial and Interchange segments in Q1.

HealthEquity (HQY) Q1 Earnings and Revenues Miss Estimates

The HSA administrator missed Wall Street's revenue and earnings estimates.

What's Behind HealthEquity's Disappointing Q1 Results

HealthEquity, Inc. (HQY) CEO Jon Kessler on Q1 2021 Results - Earnings Call Transcript

The HSA administrator also withdrew its full-year guidance due to the COVID-19 pandemic.

HealthEquity's First-Quarter Revenue and Earnings Fall Short of Estimates

HealthEquity (HQY) delivered earnings and revenue surprises of -2.27% and -1.29%, respectively, for the quarter ended April 2020. Do the numbers hold clues to what lies ahead for the stock?

HealthEquity (HQY) Lags Q1 Earnings and Revenue Estimates

Health savings account custodian HealthEquity posts results for the first quarter of fiscal 2021 after the close.

Top HSA Provider To Report Earnings As Wall Street Sees Premium To Stock

HealthEquity launches a free resource in response to record unemployment numbers HealthEquity launches a free resource in response to record unemployment numbers

News for HealthEquity Stock (HQY)